We are live on ! Find out more
BENF icon

Beneficient
BENF

21 hedge funds and large institutions have $797K invested in Beneficient in 2024 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 6 increasing their positions, 2 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

15,617% more capital inflows, than outflows

Capital inflows: $297K | Capital outflows: $1.89K

200% more repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 2

31% more funds holding

Funds holding: 16 → 21 (+5)

4.71% more ownership

Funds ownership: 17.54% → 22.25% (+4.7%)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

Holders
21
Holders Change
+5
Holders Change %
+31.25%
% of All Funds
0.28%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
5
Increased
6
Reduced
2
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
+$67.5K
2
Jane Street
Jane Street
New York
+$56.4K
3
Stifel Financial
Stifel Financial
Missouri
+$52K
4
Ausdal Financial Partners
Ausdal Financial Partners
Iowa
+$46.6K
5
Virtu Financial
Virtu Financial
New York
+$40.9K

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$1.87K
2
Tower Research Capital (TRC)
Tower Research Capital (TRC)
New York
-$17

BENF Hedge Fund Activity: Q4 2024 in Review

21 of the 7,621 institutional investors tracked by Wall St. Rank reported a position in Beneficient (BENF) for Q4 2024, worth a combined $797K — down 20% from $994K a quarter earlier.

Buyers outnumbered sellers: 5 funds opened new BENF positions and 0 closed out — a net gain of 5 holders — while 6 added to existing stakes and 2 trimmed.

The largest buyer was UBS Group, adding an estimated $67.5K. The largest seller was BlackRock, cutting an estimated $1.87K.

  • 21 institutional investors held Beneficient (BENF) as of Q4 2024, up from 16 in Q3 2024.
  • Funds reported $797K of Beneficient stock for Q4 2024, down 20% quarter-over-quarter.
  • 5 funds opened new Beneficient positions in Q4 2024 and 0 closed out, a net change of +5 holders.
  • The largest Beneficient buyer in Q4 2024 was UBS Group, an estimated $67.5K added.
  • The largest Beneficient seller in Q4 2024 was BlackRock, an estimated $1.87K sold.

Based on aggregated 13F filings for Q4 2024.